Skip to main content
Erschienen in: Current Sexual Health Reports 2/2018

21.04.2018 | Invited Commentary

Why the Sexual Tipping Point ® Is a “Variable Switch Model”

verfasst von: Michael A. Perelman

Erschienen in: Current Sexual Health Reports | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

The Sexual Tipping Point® (STP) model was designed to improve understanding about sexual response and sexual disorders. While illustrating whether a man or woman is “turned on or turned off,” it simultaneously can be used to explain in substantive detail all the complex biomedical and psychosocial-cultural factors underlying sexuality. The STP is one of a number of models previously labeled “Dual Control,” but it should instead be conceived of as a “Variable Switch” model. The reasons for this theoretical recapitulation reflects advances in our biological, psychosocial, and technological knowledge about the human body. Understanding sexuality is an iterative process and this commentary is also intended to motivate researchers/clinicians to continue improving upon and expand the STP model’s explanation of the mind/body connection inherent in sexual response and disorders [1, 2]. …
Literatur
1.
Zurück zum Zitat Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med United States. 2009;6:227–632. Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med United States. 2009;6:227–632.
2.
Zurück zum Zitat Perelman MA. Why the Sexual Tipping Point® Model? Curr Sex Health Rep Springer US. 2016;8:39–46.CrossRef Perelman MA. Why the Sexual Tipping Point® Model? Curr Sex Health Rep Springer US. 2016;8:39–46.CrossRef
3.
Zurück zum Zitat Rosenfield P. The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences. Soc Sci Med. 2002:1–15. Rosenfield P. The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences. Soc Sci Med. 2002:1–15.
4.
Zurück zum Zitat Abdo CHN, Afif-Abdo J, Otani F, Machado AC. Sexual satisfaction among patients with erectile dysfunction treated with counseling, sildenafil, or both. J Sex Med. 2008;5:1720–6.CrossRefPubMed Abdo CHN, Afif-Abdo J, Otani F, Machado AC. Sexual satisfaction among patients with erectile dysfunction treated with counseling, sildenafil, or both. J Sex Med. 2008;5:1720–6.CrossRefPubMed
5.
Zurück zum Zitat Althof SE. Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res. 2006;17:116–31. Althof SE. Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res. 2006;17:116–31.
6.
Zurück zum Zitat Perelman MA. The history of sexual medicine. In: APA handbook of sexuality and psychology, Vol. 2: contextual approaches. Washington: American Psychological Association; 2014. p. 137–79.CrossRef Perelman MA. The history of sexual medicine. In: APA handbook of sexuality and psychology, Vol. 2: contextual approaches. Washington: American Psychological Association; 2014. p. 137–79.CrossRef
7.
Zurück zum Zitat Perelman MA. Integrated sex therapy: a psychosocial-cultural perspective integrating behavioral, cognitive, and medical approaches. In: Carson CC, Kirby RS, Wyllie MG, editors. Textbook of erectile dysfunction. 2nd ed. London: Informa Healthcare; 2009. p. 298–305. Perelman MA. Integrated sex therapy: a psychosocial-cultural perspective integrating behavioral, cognitive, and medical approaches. In: Carson CC, Kirby RS, Wyllie MG, editors. Textbook of erectile dysfunction. 2nd ed. London: Informa Healthcare; 2009. p. 298–305.
8.
Zurück zum Zitat Perelman MA. Psychosocial evaluation and combination treatment of men with erectile dysfunction. Urol Clin North Am. 2005 ed. 2005;32:431–45–vi.CrossRefPubMed Perelman MA. Psychosocial evaluation and combination treatment of men with erectile dysfunction. Urol Clin North Am. 2005 ed. 2005;32:431–45–vi.CrossRefPubMed
9.
Zurück zum Zitat Phelps JS, Jain A, Monga M. The PsychoedPlusMed approach to erectile dysfunction treatment: the impact of combining a psychoeducational intervention with sildenafil. J Sex Marital Ther 2005 ed. 2004;30:305–14.CrossRefPubMed Phelps JS, Jain A, Monga M. The PsychoedPlusMed approach to erectile dysfunction treatment: the impact of combining a psychoeducational intervention with sildenafil. J Sex Marital Ther 2005 ed. 2004;30:305–14.CrossRefPubMed
10.
Zurück zum Zitat Rosen RC. Medical and psychological interventions for erectile dysfunction: toward a combined treatment approach. In: Leiblum S, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: Guilford Press; 2000. p. 276–304. Rosen RC. Medical and psychological interventions for erectile dysfunction: toward a combined treatment approach. In: Leiblum S, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: Guilford Press; 2000. p. 276–304.
11.
Zurück zum Zitat Kaplan HS. The sexual desire disorders: dysfunctional regulation of sexual motivation. New York: Brunner/Mazel, Inc; 1995. Kaplan HS. The sexual desire disorders: dysfunctional regulation of sexual motivation. New York: Brunner/Mazel, Inc; 1995.
13.
Zurück zum Zitat Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, et al. Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med. 2012;10:791–809.CrossRefPubMed Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, et al. Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med. 2012;10:791–809.CrossRefPubMed
14.
Zurück zum Zitat Perelman MA. Helen Singer Kaplan’s legacy and the future of sexual medicine. J Sex Med. 2012;9:138. Perelman MA. Helen Singer Kaplan’s legacy and the future of sexual medicine. J Sex Med. 2012;9:138.
15.
Zurück zum Zitat Bancroft J. Central inhibition of sexual response in the male: a theoretical perspective. Neurosci Biobehav Rev. 1999;23:763–84.CrossRefPubMed Bancroft J. Central inhibition of sexual response in the male: a theoretical perspective. Neurosci Biobehav Rev. 1999;23:763–84.CrossRefPubMed
17.
Zurück zum Zitat Bancroft J, Herbenick D, Barnes T, Hallam-Jones R, Wylie KR, Janssen E. The relevance of the dual control model to male sexual dysfunction: the Kinsey Institute/BASRT collaborative project. Sex Relation Ther. 2005;20:13–30.CrossRef Bancroft J, Herbenick D, Barnes T, Hallam-Jones R, Wylie KR, Janssen E. The relevance of the dual control model to male sexual dysfunction: the Kinsey Institute/BASRT collaborative project. Sex Relation Ther. 2005;20:13–30.CrossRef
18.
Zurück zum Zitat Janssen E, Bancroft J. The dual control model: the role of sexual inhibition and excitation in sexual arousal and behavior. Bloomington: Indiana University Press; 2007. Janssen E, Bancroft J. The dual control model: the role of sexual inhibition and excitation in sexual arousal and behavior. Bloomington: Indiana University Press; 2007.
19.
Zurück zum Zitat Janssen E, Vorst H, Finn P, Bancroft J. The sexual inhibition (SIS) and sexual excitation (SES) scales: I. Measuring sexual inhibition and excitation proneness in men. J Sex Res. 2002;39:114–26.CrossRefPubMed Janssen E, Vorst H, Finn P, Bancroft J. The sexual inhibition (SIS) and sexual excitation (SES) scales: I. Measuring sexual inhibition and excitation proneness in men. J Sex Res. 2002;39:114–26.CrossRefPubMed
20.
Zurück zum Zitat Kupferman I. Hypothalamus and limbic system motivation. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principle of neural science. 3rd ed. New York: Elsevier; 1991. Kupferman I. Hypothalamus and limbic system motivation. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principle of neural science. 3rd ed. New York: Elsevier; 1991.
21.
Zurück zum Zitat Stahl SM, Allers KA, Sommer B. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med United States. 2011;8:15–27.CrossRef Stahl SM, Allers KA, Sommer B. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med United States. 2011;8:15–27.CrossRef
22.
Zurück zum Zitat Arnow BA, Millheiser L, Garrett A, Polan ML, Glover GH, Hill KR, et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. NSC IBRO. 2009;158:484–502. Arnow BA, Millheiser L, Garrett A, Polan ML, Glover GH, Hill KR, et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. NSC IBRO. 2009;158:484–502.
23.
Zurück zum Zitat Pfaus JG. Pathways of sexual desire. J Sex Med United States. 2009;6:1506–33.CrossRef Pfaus JG. Pathways of sexual desire. J Sex Med United States. 2009;6:1506–33.CrossRef
24.
Zurück zum Zitat Perelman MA. Introduction: advocating for a transdisciplinary approach to the management of sexual disorders. In: Lipshultz LI, Pastuszak AW, Giraldi A, Goldstein AT, Perelman MA, editors. Management of sexual dysfunction in men and women. New York: Springer; 2016. p. 1–8. Perelman MA. Introduction: advocating for a transdisciplinary approach to the management of sexual disorders. In: Lipshultz LI, Pastuszak AW, Giraldi A, Goldstein AT, Perelman MA, editors. Management of sexual dysfunction in men and women. New York: Springer; 2016. p. 1–8.
25.
Zurück zum Zitat Isaacson W. The innovators: how a group of hackers, geniuses, and geeks created the digital revolution. New York: Simon & Schuster; 2014. Isaacson W. The innovators: how a group of hackers, geniuses, and geeks created the digital revolution. New York: Simon & Schuster; 2014.
26.
Zurück zum Zitat Bevelin P. All I want to know is where I’m going to die so I’ll never go there. Marceline: Walsworth Publishing Company; 2016. Bevelin P. All I want to know is where I’m going to die so I’ll never go there. Marceline: Walsworth Publishing Company; 2016.
28.
Zurück zum Zitat Bing S. Immortal life: a soon to be told true story. New York: Simon & Schuster; 2017. Bing S. Immortal life: a soon to be told true story. New York: Simon & Schuster; 2017.
Metadaten
Titel
Why the Sexual Tipping Point ® Is a “Variable Switch Model”
verfasst von
Michael A. Perelman
Publikationsdatum
21.04.2018
Verlag
Springer US
Erschienen in
Current Sexual Health Reports / Ausgabe 2/2018
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI
https://doi.org/10.1007/s11930-018-0148-3

Weitere Artikel der Ausgabe 2/2018

Current Sexual Health Reports 2/2018 Zur Ausgabe

Sociocultural Issues and Epidemiology (J Abdulcadir and C Johnson-Agbakwu, Section Editors)

Addressing FGM with Multidisciplinary Care. The Experience of the Belgian Reference Center CeMAViE

Clinical Therapeutics (B McCarthy and RT Segraves, Section Editors)

Treating Compulsive Sexual Behavior

Sociocultural Issues and Epidemiology (J Abdulcadir and C Johnson-Agbakwu, Section Editors)

Addressing Female Genital Mutilation/Cutting (FGM/C) in the Era of Clitoral Reconstruction: Plastic Surgery

Clinical Therapeutics (B McCarthy and RT Segraves, Section Editors)

Addressing Issues of Sexuality in Couples Therapy: Emotionally Focused Therapy Meets Sex Therapy

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.